Cas:19349-73-6 3-ethoxy-4-nitro-1-oxidopyridin-1-ium manufacturer & supplier

Chemical Name:3-ethoxy-4-nitro-1-oxidopyridin-1-ium

CAS.NO:19349-73-6

Synonyms:3-Ethoxy-4-nitropyridine 1-oxide;3-Ethoxy-4-nitropyridine N-oxide;3-Aethoxy-4-nitro-pyridin-N-oxid;3-Ethoxy-4-nitro-pyridin-N-oxyd;3-Aethoxy-4-nitro-pyridin-1-oxid

Molecular Formula:C₇H₈N₂O₄

Molecular Weight:184.14900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:80.51000

Exact Mass:184.04800

LogP:1.94520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Ethoxy-4-nitropyridine 1-oxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Aethoxy-4-nitro-pyridin-1-oxid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Aethoxy-4-nitro-pyridin-1-oxid Use and application,3-Ethoxy-4-nitropyridine 1-oxide technical grade,usp/ep/jp grade.

Related News: GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. N-(3-chloro-4-fluorophenyl)-7-methoxy-6-((5-methyl-1,3-dioxan-5-yl)methoxy)quinazolin-4-amine manufacturers GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. 3-((hydroxy-24-trioxidaneyl)oxy)-24,33,101-decaoxidan-2-one suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 3-Oxazolidineethanol, 2-hydroxy-2-methyl- vendor & factory.